Brévaut-Malaty, V.; Resseguier, N.; Garbi, A.; Tosello, B.; Thomachot, L.; Vialet, R.; Gire, C.
Long Term Neurodevelopmental Outcomes after Sevoflurane Neonatal Exposure of Extremely Preterm Children: A Cross-Sectional Observationnal Study. Children 2022, 9, 548.
https://doi.org/10.3390/children9040548
AMA Style
Brévaut-Malaty V, Resseguier N, Garbi A, Tosello B, Thomachot L, Vialet R, Gire C.
Long Term Neurodevelopmental Outcomes after Sevoflurane Neonatal Exposure of Extremely Preterm Children: A Cross-Sectional Observationnal Study. Children. 2022; 9(4):548.
https://doi.org/10.3390/children9040548
Chicago/Turabian Style
Brévaut-Malaty, Véronique, Noémie Resseguier, Aurélie Garbi, Barthélémy Tosello, Laurent Thomachot, Renaud Vialet, and Catherine Gire.
2022. "Long Term Neurodevelopmental Outcomes after Sevoflurane Neonatal Exposure of Extremely Preterm Children: A Cross-Sectional Observationnal Study" Children 9, no. 4: 548.
https://doi.org/10.3390/children9040548
APA Style
Brévaut-Malaty, V., Resseguier, N., Garbi, A., Tosello, B., Thomachot, L., Vialet, R., & Gire, C.
(2022). Long Term Neurodevelopmental Outcomes after Sevoflurane Neonatal Exposure of Extremely Preterm Children: A Cross-Sectional Observationnal Study. Children, 9(4), 548.
https://doi.org/10.3390/children9040548